{"id":"W1821838519","doi":"10.1111/j.1526-4637.2012.01478.x","title":"Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study","year":2012,"lang":"en","type":"article","venue":"Pain Medicine","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Grifols","keywords":"Medicine; Neuropathic pain; Visual analogue scale; Quality of life (healthcare); Refractory (planetary science); Adjuvant; McGill Pain Questionnaire; Clinical Global Impression; Clinical trial; Anesthesia; Physical therapy; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005879527,0.001558762,0.00248428,0.0003930205,0.0004361529,0.0008267589,0.0009645338,0.001583896,0.00202669],"category_scores_gemma":[0.003206951,0.0005317128,0.001314696,0.0005031874,0.001423966,0.0009097439,0.0003456662,0.001383293,0.0005937223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004859241,"about_ca_system_score_gemma":0.000885913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004558949,"about_ca_topic_score_gemma":0.0004100183,"domain_scores_codex":[0.9970331,0.002108324,0.0001691197,0.0002834443,0.0002301054,0.0001758439],"domain_scores_gemma":[0.9965709,0.001146841,0.0009590058,0.0003815549,0.000269558,0.0006721613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.864561,0.07114892,0.01037094,0.0005966983,0.001267377,0.0001366018,0.0002088273,0.0004327065,0.01482052,0.00004147611,0.0003362663,0.03607863],"study_design_scores_gemma":[0.297937,0.6798223,0.01954097,0.00003435296,0.0005374558,0.0001070187,0.00004777721,0.0004830777,0.0009938368,0.00003453099,0.000439411,0.00002212383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968367,0.001305711,0.0003022639,0.00005895886,0.00005435804,0.0008611825,0.0002253422,0.00002023034,0.0003354022],"genre_scores_gemma":[0.995138,0.001019139,0.0008033855,0.0002450675,0.0002778716,0.001297453,0.0007368955,0.00001176093,0.0004704941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005879527,"threshold_uncertainty_score":0.03109425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04808088824621691,"score_gpt":0.3479523996011704,"score_spread":0.2998715113549534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}